What is ZVRA's P/E ratio?

ZEVRA THERAPEUTICS INC. (ZVRA) currently trades at a P/E ratio of 5.16.

ZEVRA THERAPEUTICS INC. reports a Return on Equity (ROE) of 60.36%.

What is ZVRA's dividend yield?

ZEVRA THERAPEUTICS INC. offers a dividend yield of 0.00%.

What is ZVRA's Deepscope Quality Score?

Deepscope rates ZVRA's overall financial quality at 77 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ZVRA?

Deepscope's AI Timing Score for ZVRA is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ZVRA belong to?

ZEVRA THERAPEUTICS INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu ZVRA (NASDAQ) | ZEVRA THERAPEUTICS INC.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

ZVRA

ZEVRA THERAPEUTICS INC.

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 10.96

0.08 (0.74%) Day Change

Watchlist Portfolio Compare Chart

5.16

P/E

0.00

D/E

60.4%

ROE

44.6%

ROA

0.00%

Div Yield

-0.74

PEG

ZEVRA THERAPEUTICS INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 10.96 Price 0.08 (0.74%) Day Change	NEWS SCORE: 99

ZVRA Chất lượng tổng thể của cố phiếu Tốt ( Chất lượng = 77) và Thời điểm mua ...(Sign In to See)...

Loading chart...

77 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: Lịch sử ROE tương đối thấp
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Khá , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng

66%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	73 GOOD
Magic Formula Rank by ROE	73 GOOD
Magic Formula Rank by ROIC	76 GOOD
Price	10.96
PBV / Sector	3.13 / 4.48
Earning Per Share	2.12

PE / Sector	5.16 / 16.68 GREAT
PEG or PE/Growth / Sector	-0.74 / 0.53
Average 1M Daily Value	21.27 M GREAT
Average 1W Daily Value	23.11 M GREAT

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

66%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	101.58 / 450.37 GREAT
NPM Average (%) / Sector	-139.65 / -1,506.30
NPM Change Average (%) / Sector	10.64 / 4,941.44 GOOD
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	44.59 / 30.83 GREAT
ROA Average (%) / Sector	-7.07 / -347.12
ROA Change Average (%) / Sector	10.00 / 5,126.35 GOOD
ROE (%) / Sector	60.36 / -3.04 GREAT
ROE Average (%) / Sector	-52.38 / 40.76
ROE Change Average (%) / Sector	64.53 / 2,110.63 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

Chi tiết đăng ký

Analyze Date	2026-06-04 09:24:03
Symbol	ZVRA
Name	ZEVRA THERAPEUTICS INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	59.12 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	643.17 / 8,483.11

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 101 Federal Street, Boston, MA, United States, 02110

Phone: 888 958 1253

Website: https://www.zevra.com

Employees: 61

Sector: Healthcare >> Biotechnology

Description: Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 3 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase 3 clinical trial to treat narcolepsy. The company is developing Celiprolol, an investigational product candidate that is under Phase 3 clinical trial for the treatment of vascular Ehlers Danlos syndrome. In addition, it offers AZSTARYS, a once-daily treatment for attention deficit and hyperactivity disorder in patients aged six years and older; OLPRUVA to treat urea cycle disorders; and MIPLYFFA for the treatment of niemann-pick disease type C, an ultra-rare neurodegenerative disease. The company has collaboration and license agreement with Commave Therapeutics SA to develop, manufacture and commercialize the company's product candidates containing SDX and d-methylphenidate; and license agreement with Acer and Relief Therapeutics, Inc. to develop and commercialize rights for OLPRUVA. The company was formerly known as KemPharm, Inc. and changed its name to Zevra Therapeutics, Inc. in February 2023. The company was incorporated in 2006 and is headquartered in Boston, Massachusetts.